Celltrion | 068270 - Cost Of Sales

Stock Price
179,400.00
Daily Change
-3,100.00 -1.70%
Monthly
-11.63%
Yearly
14.56%
Q2 Forecast
177,698.56

Celltrion reported KRW107.42B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Celltrion KRW 107.42B 295.44B Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Moderna USD 955M 503M Mar/2026
Organon & Co USD 766M 21M Dec/2025
Revvity USD 323.46M 26.93M Mar/2026
Viatris USD 2.36B 195.9M Mar/2026
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025